• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Explora BioLabs Acquires Cambridge Vivarium Service Provider Novalex

Share:

June 15, 2021

Explora BioLabs, a national provider of preclinical vivarium space, vivarium management services, and contract research services, today announced it has completed its acquisition of Novalex Biotech Resources, LLC, a vivarium service provider based here.

The acquisition expands Explora BioLabs’ OnSite vivarium management services to the Boston-area biotechnology market.

“Explora BioLabs was attracted to Novalex’s strong alignment of values, client relationships, and standards of client support—principles that Explora shares,” said Sandy Paige, CEO of Explora BioLabs. “The Novalex team has a passion for customer service and understanding of Boston biotech, making them a welcome addition to our Explora team.”

“We’ve built strong relationships with our clients over the years. They will be well-cared-for by Explora,” said Jason Saraceni, founder and president of Novalex. “I’m confident that Explora’s expanded vivarium and contract research services will help our clients and the Novalex team realize their potential, and I look forward to joining the talented Explora team.”

New Benefits to Customer

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Following the acquisition, existing Novalex clients and new customers alike will have access to Explora’s comprehensive suite of vivarium management, husbandry, regulatory, and technician support services. From increased staffing and service flexibility to access to local contract research services and preferred partner network pricing, researchers operating under Explora’s care will experience greater capital and operational efficiencies as they remain focused on their scientific research.

Supercharging Boston Biotech Research

Explora has accelerated the introduction of its comprehensive Vivarium-as-a-Service model to the Boston market with the acquisition of Novalex and the opening of its new, state-of-the-art vivarium facility and contract research service in Watertown. Explora remains committed to empowering both local and national biotech researchers, enabling them to focus on their research instead of vivarium management. Explora’s vivaria management services are capital efficient and deliver the flexibility of expanding or contracting research activity without disruption. Explora’s Watertown contract research services support researchers in meeting their scientific milestones with options ranging from à-la-carte technical services to complete study execution.

“Whenever we have the opportunity to join other great teams of in vivo services, we’ll jump at the chance,” said Paige. “Jason Saraceni founded Novalex on the same premise that Dr. Richard Lin founded Explora: biotechs should be empowered to focus on the promise of their science, not worrying about cage changes and ordering supplies. Service partners like Explora can empower them by delivering the non-core operations biotechs need with greater flexibility, speed, and capital efficiency.”

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Pfizer sells $523M stake in ICU Medical to C.P. PharmaceuticalsPfizer sells $523M stake in ICU Medical to C.P. Pharmaceuticals
  • Facebook Connects Users to COVID-19 Vaccine Finder ToolFacebook Connects Users to COVID-19 Vaccine Finder Tool
  • Applying Data Science Principles to FDA’s PreCert Program: Some Scary StuffApplying Data Science Principles to FDA’s PreCert Program: Some Scary Stuff
  • Sales of Bioprocess Technology Set to Expand By 5x as Application in Biopharmaceutical Industry Rises: Future Market InsightsSales of Bioprocess Technology Set to Expand By 5x as Application in Biopharmaceutical Industry Rises: Future Market Insights
  • Where blockchain in healthcare might actually make a differenceWhere blockchain in healthcare might actually make a difference
  • 2020 Insights on the Covid-19 Impact on Medical Respiratory Mask Market Research, Growth and Estimation Forecast By 20252020 Insights on the Covid-19 Impact on Medical Respiratory Mask Market Research, Growth and Estimation Forecast By 2025
  • Life Science, Health & Wellness Monthly TechVision Opportunity Reports – Collection of Disruptive and Ground-Breaking Technological Innovations Across the Global Healthcare Landscape – ResearchAndMarkets.comLife Science, Health & Wellness Monthly TechVision Opportunity Reports – Collection of Disruptive and Ground-Breaking Technological Innovations Across the Global Healthcare Landscape – ResearchAndMarkets.com
  • Khiron Receives Regulatory Approval for Uruguay AcquisitionKhiron Receives Regulatory Approval for Uruguay Acquisition

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications